The ctDNA discovery rates were 14.81%, 15.00%, and 39.76% in patients with no lesions, localized, and metastatic disease on PSMA PET imaging, respectively (P = 0.013) (Fig. 2C). Here, FOLH1 is linked to metastatic neoplasm.